TEXASLDPC INC. v. BROADCOM INC.
Authored by: Jeremy J. Gustrowsky
A university spinoff that ran out of customers and pivoted to enforcing its patents can keep its lawsuit alive and pursue it without dragging the university into court. In a decision reversing a Delaware district court, the Federal Circuit held that an exclusive license from Texas A&M University to TexasLDPC Inc. never terminated, that it handed over “all substantial rights” in the licensed patents, and that the university was not a party that had to be joined.
The case revolves around low density parity check (LDPC) technology, a form of error correction code that detects and fixes errors in transmitted data signals. The inventions came out of doctoral research at Texas A&M, which patented the technology and later granted an exclusive license to TexasLDPC covering five patents (U.S. Patent Nos. 8,418,023; 8,555,140; 9,112,530; 8,359,522; and 8,656,250) plus three copyrights on related source code. In exchange, the university received equity in the company, a slice of any sublicensing royalties, and a share of anything recovered through enforcement. TexasLDPC sued Broadcom, LSI, and Avago in 2018, but did not name Texas A&M as a co-plaintiff. By the summer of 2019, the company had burned through its capital without landing a single customer or sublicensee, and it redirected its energy entirely toward the litigation.
That pivot became the defendants’ opening. They argued the license had automatically ended under a clause terminating the agreement the moment TexasLDPC “ceases its business operations,” and the district court agreed, reasoning that the agreement’s opening recitals emphasized commercializing the technology and that enforcement was only an “ancillary” activity. The Federal Circuit read the contract differently. Applying Texas law, the court pointed to operative provisions that repeatedly assume enforcement would be part of the company’s work, including a definition of “commercially reasonable efforts” that expressly covers efforts “to enforce Copyrights or Patent Rights,” a clause barring termination for missing sales targets so long as the company was pursuing enforcement, and a payment structure that contemplated money coming from infringement recoveries. Under Texas law, recitals cannot override clear operative terms, and the broad, generic “whereas” language here could not shrink the meaning of “business operations.”
On the second ground for dismissal, the court walked through the familiar question of whether a license transfers enough ownership that the licensee may sue alone. TexasLDPC held an exclusive right to make, use, and sell the licensed products, to grant sublicenses of the same scope, and the “first and only right” to sue infringers and collect damages for past, present, and future infringement, all for the life of the patents and none of it subject to the university’s approval. Texas A&M kept only a research and educational use right, the sole ability to sue one earlier non-exclusive licensee (Marvell), a right to join certain suits, an assignment-approval right that could not be unreasonably withheld, and a milestone-based termination right that everyone agreed had already been satisfied. Calling it a close call, the panel found the arrangement closest to its 2016 Luminara decision rather than to Propat, where the patent owner could veto licensing and litigation decisions and never conveyed make, use, or sell rights at all. The narrow carve-out for Marvell also differed in scale from the pre-approved target list that defeated the licensee in Lone Star.
The most practically useful part of the opinion may be the Rule 19 discussion. Because the university had given away all substantial rights, its absence could not impair its own interests or expose the defendants to duplicate suits. The district court had separately concluded it could not grant “complete relief” without Texas A&M because the university had successfully asserted sovereign immunity to quash a discovery subpoena, and the defendants wanted its licensing records for the Georgia-Pacific reasonable royalty analysis. The Federal Circuit rejected that reasoning in blunt terms: Rule 19 is not a discovery tool. Joining other circuits, the court explained that needing evidence from someone does not make that someone a required party. The point was reinforced by the record, since the only two directly relevant licenses had already been produced and the defendants’ own damages expert had managed to analyze every Georgia-Pacific factor without the additional material.
The practical takeaway for licensing lawyers is twofold. First, if a licensee’s business plan may eventually narrow to enforcement, make sure the operative terms say so, because aspirational recitals about commercialization can be used against you. Second, when a university or other immune entity is the patent owner, an exclusive license that conveys unfettered rights to practice, sublicense, and sue can let the licensee litigate on its own, and an accused infringer cannot convert a discovery inconvenience into a dismissal. Having resolved the case under Rule 19(a), the court did not need to reach the district court’s balancing of the Rule 19(b) equitable factors, nor the effect of a nunc pro tunc agreement the parties had signed mid-litigation.